INVENTIVA (EPA:IVA) | WebDisclosure

Basculer en Français

9866	Companies
198282	Keywords
129317	Articles
105443	Press releases

Home
Companies
INVENTIVA

BRIEF

published on 03/26/2025 at 21:05, 10 months 19 days ago

Inventiva unveils its 2024 financial results and strategic projects

Strategic Reorganization 2024 Financial Results Research & Development Lanifibranor Structured Financing
PRESS RELEASE

published on 03/26/2025 at 21:00, 10 months 19 days ago

Inventiva publie ses résultats financiers annuels 2024 et fait le point sur son activité
Inventiva publie ses résultats financiers annuels 2024 et fait le point sur son activité avec chiffre d'affaires de 9,2 millions d'euros, trésorerie à 96,6 millions d'euros et levée de 116 millions d'euros

Chiffre D'affaires Résultats Financiers Financement Trésorerie Inventiva
PRESS RELEASE

published on 03/26/2025 at 21:00, 10 months 19 days ago

Inventiva reports its 2024 full year results and provides a business update
Inventiva reports its 2024 full year financial results with revenues of €9.2 million, cash equivalents of €96.6 million and a structured financing of up to €348 million. Significant progress in the NATiV3 Phase 3 trial of lanifibranor for MASH. Pipeline prioritization plan presented

Revenues Financial Results Inventiva Cash Equivalents NATiV3 Phase 3 Trial
BRIEF

published on 03/19/2025 at 21:05, 10 months 26 days ago

Inventiva Announces 2024 Full-Year Financial Results Schedule

Financial Results Webcast Inventiva Lanifibranor MASH Treatment
BRIEF

published on 03/19/2025 at 21:05, 10 months 26 days ago

Inventiva annonce le calendrier des résultats financiers annuels 2024

Résultats Financiers Webcast Inventiva Lanifibranor Traitement MASH
PRESS RELEASE

published on 03/19/2025 at 21:00, 10 months 26 days ago

Inventiva announces the schedule of publication and presentation of its 2024 Full-Year Financial Results
Inventiva schedules 2024 Full-Year Financial Results presentation on March 27, 2025. Webcast available. Company focused on small molecule therapies for MASH

Presentation 2024 Financial Results Inventiva MASH Small Molecule Therapies
PRESS RELEASE

published on 03/19/2025 at 21:00, 10 months 26 days ago

Inventiva annonce la date de publication et de présentation de ses résultats financiers 2024
Inventiva annonce la date de publication et de présentation de ses résultats financiers 2024. La présentation aura lieu le 27 mars 2025 avec une conférence téléphonique le 30 mars 2025

Presentation Conférence Téléphonique Thérapies Orales Résultats Financiers 2024 Inventiva
BRIEF

published on 02/26/2025 at 22:05, 11 months 16 days ago

Inventiva's Lanifibranor Shows Promise in Portal Hypertension Study

Preclinical Study Inventiva Liver Disease Lanifibranor Portal Hypertension
BRIEF

published on 02/26/2025 at 22:05, 11 months 16 days ago

Lanifibranor d'Inventiva se révèle prometteur dans une étude sur l'hypertension portale

Inventive Maladie Du Foie Étude Préclinique Lanifibranor Hypertension Portale
PRESS RELEASE

published on 02/26/2025 at 22:00, 11 months 16 days ago

Inventiva announces the publication in Biomedicine & Pharmacotherapy of the results from a preclinical study showing improvement of portal hypertension with lanifibranor treatment
Inventiva announces publication in Biomedicine & Pharmacotherapy of preclinical study results indicating lanifibranor's effectiveness in improving portal hypertension, potentially addressing complications of chronic liver diseases

Preclinical Study Inventiva Lanifibranor Portal Hypertension Biomedicine & Pharmacotherapy

Accesswire

Published on 02/14/2026 at 01:00, 1 day 11 hours ago

Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:30, 1 day 14 hours ago

Norse Gold Corp. Announces New Director
Published on 02/13/2026 at 22:15, 1 day 14 hours ago

Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 1 day 18 hours ago

Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 1 day 22 hours ago

Datametrex Received $500,000 Purchase Order For Data Centre Solutions

View all ACCESSWIRE

EQS Group

Published on 02/15/2026 at 11:43, 1 hour 1 minute ago

EQS-Adhoc: The Management Board of Hapag-Lloyd Aktiengesellschaft confirms negotiations regarding an acquisition of Zim Integrated Shipping Services Ltd.
Published on 02/15/2026 at 11:05, 1 hour 39 minutes ago

WePlay Debuts in German Market with "The Little Prince" Special Valentine's Day Collaboration
Published on 02/15/2026 at 09:35, 3 hours 9 minutes ago

Canary Islands at the Berlinale European Film Market with more than 40 professionals from the islands
Published on 02/14/2026 at 16:30, 20 hours 14 minutes ago

Milano Cortina 2026 Licensed Candies Released Globally
Published on 02/14/2026 at 06:05, 1 day 6 hours ago

The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities

Les Echos

Published on 02/14/2026 at 07:00, 1 day 5 hours ago

Groupe DLSI - Chiffre d'affaires 2025
Published on 02/13/2026 at 18:05, 1 day 18 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 1 day 18 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 1 day 18 hours ago

Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 1 day 18 hours ago

Nombre total d'actions et droits de vote - janvier 2026

View all LES ECHOS COMFI WIRE